Executive Summary
The September 16, 2026 proxy season reveals a bifurcated executive compensation landscape: while most filers show stable or modestly growing pay, two companies exhibit extreme pay-for-performance divergence—QuinStreet's CEO saw compensation actually paid fall 55.8% YoY on a 69% drop in reported total comp, while Nu Ride's multi-year equity vesting schedules suggest potential overhang.
Capital raises dominate the agenda, with Gossamer Bio's $125M contingent private placement and Coatue's fee-in-shares proposal highlighting a trend toward non-cash or milestone-based financing, while TriCo Bancshares' pending merger with First Hawaiian (2.095x exchange ratio) signals consolidation in regional banking. Governance quality is mixed: STRATTEC maintains 100% board attendance and 6/7 independent directors, but Nu Ride's 'say on pay' frequency proposal (2 years) and Coatue's concentration policy change (25% in tech/comm/industrial) raise red flags. The most actionable signals center on dilution risk (Gossamer, Nu Ride), insider alignment (James River's director waiving comp), and the TriCo/FHB merger arb spread. Watch for Gossamer's NDA acceptance milestone by Dec 31, 2026, and the TriCo/FHB shareholder votes in Q4 2026.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: DEF 14A · DEFM14A
Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from September 15, 2026.
Investment Signals (10)
- QuinStreet ↓ (BEARISH)▲
CEO actual pay fell 55.8% YoY to $1.82M (from $4.12M), with total comp down 69% to $2.39M; equity grant value dropped 73% to $1.91M, signaling pay-for-performance alignment but also potential retention risk
- TriCo Bancshares ↓ (BULLISH)▲
Merger with First Hawaiian at 2.095x exchange ratio; KBW/Evercore opinions dated July 12, 2026; regulatory approvals pending from Fed, FDIC, Hawaii DFI, California DFPI—arb spread likely to narrow as deal closes
- Gossamer Bio ↓ (BEARISH)▲
$25M initial closing (Aug 24, 2026) with up to $125M second closing contingent on NDA acceptance by Dec 31, 2026; if stock price <$11.192, more shares issued (e.g., 15.6M at $8.00), creating dilution overhang
- STRATTEC ↓ (BULLISH)▲
FY2026 net sales +2.5% YoY, gross margin +150 bps, 100% board attendance, 6/7 independent directors; strong balance sheet with cash on hand—no operational presentation at AGM suggests steady-state
- James River Group ↓ (BULLISH)▲
Director Botein waives compensation per Investment Agreement; CEO ownership guideline at 5x salary, directors 3x retainer—strong alignment; Top Workplaces recognition 6th year, employee engagement 71%
-
Proposal to pay adviser fees in Fund Shares (12-month lock-up) and amend concentration policy to 25% tech/comm/industrial; board expects net neutral NAV impact—watch for fee alignment [NEUTRAL/BULLISH]
- Nu Ride ↓ (BEARISH)▲
CEO Alexander Matina's equity grants vest over 3 years (2023-2025), with FY2025 total comp likely elevated; reverse split authorization and >19.99% issuance proposal signal potential dilution
- Elmet Group ↓ (NEUTRAL)▲
ESPP adoption proposal at special meeting Oct 19, 2026; 30.5M shares outstanding, quorum 33.34%—low participation risk if retail holders don't vote
- First Hawaiian (FHB) (BULLISH)▲
Merger with TriCo provides geographic expansion into West Coast; exchange ratio fixed at 2.095, but Evercore opinion dated July 12—watch for renegotiation if TriCo underperforms
- QuinStreet (Non-PEO NEOs) (NEUTRAL)▲
Average actual pay for other NEOs rose 13.6% to $1.82M, while CEO pay fell 55.8%—pay compression between CEO and team may signal succession planning or governance shift
Risk Flags (8)
- Gossamer Bio↓ [HIGH RISK]▼
Dilution risk HIGH—if stock price <$11.192 at second closing, additional 15.6M+ shares issued; NDA acceptance milestone may not occur by Dec 31, 2026, terminating obligations
- Nu Ride↓ [HIGH RISK]▼
Reverse stock split authorization and >19.99% share issuance proposal (Proposal Three) signal potential capital raise at below-market prices; 2-year say-on-pay frequency reduces shareholder oversight
- TriCo Bancshares↓ [MEDIUM RISK]▼
Merger integration risks—loss of key employees, regulatory delays (Fed, FDIC, Hawaii, California), and market fluctuations could impair deal value; Evercore/KBW opinions dated July 12 may be stale
- QuinStreet↓ [MEDIUM RISK]▼
CEO compensation volatility—actual pay down 55.8% YoY, total comp down 69%; potential retention risk for key executive talent, especially if stock underperforms
- Coatue↓ [MEDIUM RISK]▼
Concentration policy change to 25% in tech/comm/industrial increases sector risk; fee-in-shares could dilute NAV if fund shares trade at premium
- James River↓ [LOW RISK]▼
Director compensation increase (equity awards doubled to $100K, Chair to $150K) first since 2023—may signal governance shift or retention need, but low materiality
- STRATTEC↓ [LOW RISK]▼
No operational presentation at AGM (Oct 13) and missing EPS/cash flow data in filing—lack of forward guidance may disappoint investors expecting updates
- Elmet Group↓ [LOW RISK]▼
ESPP proposal only item—low engagement; quorum at 33.34% could fail if retail turnout is low, delaying plan adoption
Opportunities (8)
- TriCo Bancshares↓ (OPPORTUNITY)◆
Merger arb play—deal expected to close Q1 2027; regulatory approvals pending, but 2.095x exchange ratio offers spread if FHB appreciates; monitor shareholder votes in Q4 2026
- Gossamer Bio↓ (OPPORTUNITY)◆
If NDA acceptance milestone hits by Dec 31, 2026, second closing brings $125M at $11.192/share—potential upside if clinical data positive; watch for insider buying post-announcement
- STRATTEC↓ (OPPORTUNITY)◆
Margin expansion (+150 bps) and 2.5% revenue growth with strong balance sheet—trading at reasonable valuation; AGM Oct 13 could provide color on FY2027 guidance
- QuinStreet↓ (OPPORTUNITY)◆
CEO pay cut 55.8% aligns with performance—if stock recovers, pay will rise; current valuation may be depressed, offering entry for patient investors
- James River↓ (OPPORTUNITY)◆
Director compensation increase signals board refreshment; employee engagement 71% and Top Workplaces recognition—positive culture could drive retention and operational efficiency
- Coatue↓ (OPPORTUNITY)◆
Fee-in-shares aligns adviser with shareholders; 12-month lock-up prevents immediate selling—if fund NAV outperforms, shares could trade at premium
- Nu Ride↓ (OPPORTUNITY)◆
If reverse split and share issuance approved, company may raise capital for growth—watch for insider buying post-approval; current valuation may not reflect turnaround potential
- First Hawaiian (OPPORTUNITY)◆
Post-merger, combined entity gains scale in Hawaii and West Coast—cost synergies could drive EPS accretion; monitor integration milestones
Sector Themes (5)
- Executive Pay-for-Performance Divergence◆
2/10 filers show extreme pay cuts (QuinStreet CEO -55.8%, Nu Ride CEO pay tied to 3-yr vesting), while others (James River, STRATTEC) maintain stable pay—investors should scrutinize pay vs. TSR alignment
- Capital Raise Dilution Overhang◆
3/10 filers (Gossamer, Nu Ride, Coatue) propose or execute dilutive financings—Gossamer's $125M contingent placement and Nu Ride's >19.99% issuance signal sector-wide need for cash
- M&A in Regional Banking◆
TriCo/FHB merger (2.095x exchange ratio) highlights consolidation trend; regulatory approvals (Fed, FDIC, state) will set precedent for deal timelines
- Governance and Say-on-Pay Frequency◆
Nu Ride's 2-year frequency proposal and Coatue's concentration policy change indicate governance divergence—investors may push back on reduced oversight
- Employee Engagement as Value Driver◆
James River (71% engagement, Top Workplaces 6th year) and STRATTEC (100% board attendance) show positive culture correlates with operational stability—watch for HR metrics in future filings
Watch List (6)
-
NDA acceptance milestone due by Dec 31, 2026; second closing of $125M at $11.192/share—watch for FDA communication and insider buying [date: Dec 31, 2026]
-
Shareholder vote on merger with First Hawaiian—regulatory approvals from Fed, FDIC, Hawaii, California pending; monitor proxy voting and deal timeline [date: Q4 2026]
-
Annual Meeting Oct 13, 2026—no operational presentation, but watch for any guidance or commentary on FY2027 [date: Oct 13, 2026]
- 👁
Annual Meeting Nov 9, 2026—vote on reverse split and share issuance; monitor post-meeting capital raise announcements [date: Nov 9, 2026]
- 👁
Special Meeting Oct 28, 2026—approval of fee-in-shares and concentration policy; watch for fund NAV impact and share issuance [date: Oct 28, 2026]
-
Special Meeting Oct 19, 2026—ESPP adoption; low quorum risk, monitor turnout [date: Oct 19, 2026]
Filing Analyses
(10)
16-09-2026
James River Group Holdings, Inc. filed its definitive proxy statement (DEF 14A) on September 16, 2026, detailing director compensation, executive officer biographies, and employee-related initiatives. The company reported 576 employees as of December 31, 2025, and achieved a 71% participation rate in its October 2025 employee engagement survey, earning Top Workplaces USA recognition for the sixth consecutive year. Director compensation was increased in February 2026 for the first time since 2023, with annual equity awards for non-employee directors rising from $50,000 to $100,000 and the Chair's equity award increasing from $100,000 to $150,000.
- · Director Matthew Botein does not receive compensation for his service as a director, pursuant to the terms of the Investment Agreement relating to the issuance of Series A Preferred Shares.
- · The company's stock ownership guidelines require the CEO to own shares worth five times annual base salary, other executive officers three times, and non-employee directors three times their annual cash retainer.
- · The company was named a 2026 Top Workplace by the Richmond-Times Dispatch for the fourth consecutive year and tenth time overall.
- · Joel D. Cavaness joined the Board on July 21, 2025 and received a pro-rated restricted share unit award of 5,479 shares.
- · Ollie L. Sherman, Jr. served as a director until his retirement on April 30, 2025.
16-09-2026
STRATTEC SECURITY CORP filed its DEF 14A proxy statement for the 2026 Annual Meeting to be held on October 13, 2026. The filing highlights FY 2026 financial results with net sales increasing 2.5% YoY, gross profit margin improvement of 150 basis points, and a strong balance sheet with cash on hand. However, the diluted EPS and cash flow from operations figures are not explicitly provided in the extracted text, and the filing notes that there will be no presentation regarding operations at the meeting. Governance highlights include 6 of 7 independent directors, separate Chair and CEO roles, and 100% board attendance.
- · Annual Meeting scheduled for October 13, 2026 at The Pfister Hotel, Milwaukee, WI at 8:00 a.m. local time.
- · Record date for voting is August 14, 2026.
- · No presentation regarding operations will be made at the Annual Meeting.
- · Proxy materials expected to be mailed on or about September 16, 2026.
- · Board has 7 director nominees; 6 are independent.
- · 5 of 6 independent directors have been added in the last 5 years, indicating recent board refreshment.
- · 100% attendance at board meetings.
- · Company engaged with 77 investors, representing 29% of the 3.5 million shares held by institutional holders.
- · Director skills matrix shows all 7 directors have senior executive leadership, public company governance, financial reporting, strategy & capital allocation, M&A, and risk management skills.
- · Jennifer Slater was recognized by Automotive News 100 leading women in 2025.
- · Richard P. Messina transitioned from SVP and CTO to Engineering Technical Fellow in March 2026.
16-09-2026
Elmet Group Co. filed a definitive proxy statement (DEF 14A) for a special meeting of stockholders to be held virtually on October 19, 2026. The sole proposal is to approve the adoption of the 2026 Employee Stock Purchase Plan (ESPP). The board recommends a vote FOR the proposal. The record date is August 28, 2026, with 30,459,498 shares of common stock outstanding and entitled to vote.
- · Special meeting will be held virtually on October 19, 2026 at 1:00 p.m. Eastern Time.
- · Record date for voting is August 28, 2026.
- · Quorum requirement is one-third (33.34%) of outstanding shares.
- · Proxy materials are expected to be first sent on or about September 17, 2026.
- · Internet voting closes at 11:59 p.m. Eastern Time on October 18, 2026.
- · Shares held in street name may be voted by the nominee if no instructions are given, but only on routine matters.
16-09-2026
QuinStreet, Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders, disclosing executive compensation details for fiscal year 2026. CEO Doug Valenti's compensation actually paid fell sharply to $1,819,579 in FY2026 from $4,115,402 in FY2025, a decline of approximately 55.8%, while the average compensation actually paid to other named executive officers (Non-PEO NEOs) increased to $1,819,579 from $1,602,294, a rise of about 13.6%. The filing also shows that total compensation as reported in the Summary Compensation Table for the CEO dropped to $2,386,325 in FY2026 from $7,692,200 in FY2025, a decrease of approximately 69.0%.
- · CEO Doug Valenti's grant date fair value of stock and option awards granted in FY2026 was $1,911,600, down from $7,102,200 in FY2025.
- · The fair value at fiscal year end of outstanding and unvested stock/option awards granted in FY2026 for the CEO was $1,728,700, compared to $3,059,000 in FY2025.
- · The change in fair value of outstanding and unvested stock/option awards granted in prior fiscal years for the CEO was positive $160,358 in FY2026 versus negative $189,293 in FY2025.
- · For Non-PEO NEOs, the grant date fair value of stock and option awards granted in FY2026 averaged $1,911,600, down from $2,140,940 in FY2025.
- · The fair value at fiscal year end of outstanding and unvested stock/option awards granted in FY2026 for Non-PEO NEOs averaged $1,728,700, up from $922,128 in FY2025.
- · The change in fair value of outstanding and unvested stock/option awards granted in prior fiscal years for Non-PEO NEOs was positive $160,328 in FY2026 versus negative $50,474 in FY2025.
16-09-2026
Nu Ride Inc. (NRDE) filed its definitive proxy statement (DEF 14A) on September 16, 2026, for the 2026 Annual Meeting to be held virtually on November 9, 2026. The filing discloses executive compensation details for named executive officers (NEOs) including Alexander Matina, William Gallagher, and Edward T. High Tower for fiscal years 2023, 2024, and 2025. The proxy statement provides stockholders with proposals to vote on and outlines the procedures for the virtual meeting.
- · The 2026 Annual Meeting will be held virtually on November 9, 2026, at 12:00 pm New York City time.
- · The record date for stockholders entitled to vote is September 15, 2026.
- · Proxy materials were made available on or about September 16, 2026.
- · The filing includes compensation data for NEOs for fiscal years 2023, 2024, and 2025.
16-09-2026
Gossamer Bio is seeking stockholder approval to issue additional shares in connection with a private placement that raised approximately $25.0 million at the initial closing and could raise up to $125.0 million at a second closing, contingent on an NDA acceptance milestone. The proposal involves the issuance of common stock upon exercise of pre-funded warrants and FDA approval warrants, and conversion of preferred stock, with participation by executive officers and directors. While the funding provides near-term capital, the second closing is contingent on milestones and may not occur by December 31, 2026, and the company faces potential dilution and a lower conversion price if the stock price declines.
- · The Purchase Agreement was entered into on August 20, 2026, with the Initial Closing on August 24, 2026.
- · The Second Closing is contingent on the NDA Acceptance Milestone occurring in 2026 and other closing conditions; if not closed by December 31, 2026, obligations terminate.
- · If the volume-weighted average price per share of Common Stock during the five trading days before the Second Closing is less than $11.192, the purchase price per Second Closing Pre-Funded Warrant will be lower, and the warrants would be exercisable for additional shares (e.g., at $8.00, approximately 15,625,000 shares).
- · The conversion price of Series A-2 Preferred Stock will be the lesser of $11.20 and the five-day VWAP preceding the Second Closing.
- · Preferred Stock carries a 4x liquidation preference prior to Stockholder Approval, which is eliminated after approval.
- · Beneficial ownership limitations cap conversion at 9.99% (up to 19.99% upon election) of outstanding Common Stock.
- · A registration statement for resale of Registrable Securities must be filed within 30 days after Stockholder Approval.
- · Gregory A. Ciongoli was appointed to the Board on September 16, 2026, and is a Purchaser under the Purchase Agreement.
16-09-2026
Coatue Innovative Strategies Fund is holding a Special Meeting on October 28, 2026, to approve two key proposals: (1) allowing the Adviser to receive management and/or incentive fees in Fund Shares instead of cash, and (2) amending the Fund's fundamental concentration policy to require at least 25% of total assets in technology, communication, and industrial sectors. The fee-in-shares proposal is designed to reduce liquidity risk from forced asset sales and align Adviser interests with shareholders, while the concentration change provides flexibility for technology-oriented investments. The Board recommends voting FOR both proposals, and the Fund's fee rates and investment strategies will remain unchanged.
- · The Adviser will commit to forgo selling Shares received as fees for at least 12 months from issuance, except in exceptional circumstances.
- · The Amended Advisory Agreement will operate for an initial two-year period, then continue annually if approved by the Board, including Independent Trustees.
- · The Board will annually review the Share payment policy's impact on Fund earnings and NAV per Share, with the expectation of a net neutral effect.
- · The Fund's investment objective and principal investment strategies will remain the same if Proposals are approved.
- · Shareholders of record as of June 30, 2026, are entitled to vote at the Special Meeting.
- · The Adviser will 'mirror vote' any Shares received in lieu of cash, voting in proportion to other non-affiliated shareholders.
16-09-2026
Inland Real Estate Income Trust, Inc. filed its definitive proxy statement (DEF 14A) on September 16, 2026, for the annual meeting scheduled on November 5, 2026. Stockholders will vote on the election of three Class II directors, ratification of KPMG LLP as independent auditor for fiscal year 2026, and a non-binding advisory vote on executive compensation. The board recommends a vote 'FOR' all proposals.
- · Annual meeting date: November 5, 2026 at 2:00 p.m. Central Time at 2901 Butterfield Road, Oak Brook, Illinois.
- · Record date for voting: September 14, 2026.
- · Notice of Internet Availability of Proxy Materials to be mailed on or about September 25, 2026.
- · Stockholders may vote via Internet, telephone, or mail; proxy deadline is 11:59 p.m. Eastern Time on November 4, 2026.
- · If no voting instructions are given, proxies will be voted FOR all three proposals.
- · Proposal 1: Elect Stephen L. Davis, Anthony Chereso, and Alan Feldman as Class II directors (term until 2029 annual meeting).
- · Proposal 2: Ratify KPMG LLP as independent auditor for fiscal year ending December 31, 2026.
- · Proposal 3: Non-binding advisory vote on named executive officer compensation.
16-09-2026
Polar Power, Inc. filed a preliminary proxy statement (DEF 14A) for its Annual Meeting scheduled for October 14, 2026, with a record date of September 9, 2026. The meeting includes eight proposals, notably the election of six directors, approval of a potential issuance of over 19.99% of outstanding common stock in non-public financings (Proposal Three), and authorization for a reverse stock split (Proposal Four). The Board recommends a 'FOR' vote on all proposals, but the reverse split and stock issuance proposals signal potential dilution and capital-raising needs, which may concern investors.
- · Proposal Three seeks approval for potential issuance of shares exceeding 19.99% of outstanding common stock at below-market prices, subject to Nasdaq Listing Rule 5635(d).
- · Proposal Four authorizes a reverse stock split at a ratio ranging from one-for-three to one-for-ten, to be effected at the Board's discretion before December 31, 2027.
- · Proposal Six (Say on Pay Frequency) recommends a two-year frequency, with proxies voted accordingly if no direction is given.
- · Broker non-votes are not expected on Proposals Two and Four as they are routine matters under NYSE rules.
- · Shares held in street name require broker instructions for non-routine proposals (One, Three, Five, Six, Seven).
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 10 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Compensation Proxy SEC Filings
September 14, 2026
US Executive Compensation Proxy SEC Filings — September 14, 2026
September 11, 2026
US Executive Compensation Proxy SEC Filings — September 11, 2026
September 10, 2026
US Executive Compensation Proxy SEC Filings — September 10, 2026
September 09, 2026
US Executive Compensation Proxy SEC Filings — September 09, 2026
🇺🇸 More from United States
View all →September 17, 2026
US Merger & Acquisition SEC Filings — September 17, 2026
US Merger & Acquisition SEC Filings
September 17, 2026
US Corporate Board Director Changes SEC Filings — September 17, 2026
US Corporate Board Director Changes SEC Filings
September 16, 2026
US Pre-Market SEC Filings Roundup — September 16, 2026
US Pre-Market SEC Filings Roundup
September 16, 2026
S&P 500 Healthcare Sector SEC Filings — September 16, 2026
S&P 500 Healthcare Sector SEC Filings